Neurocrine Biosciences (NBIX)
56.74
+0.05 +0.09%
NASDAQ
Sep 19, 11:19
Delayed 2m
USD
View All Key Stats
NBIX Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.53 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -219.86M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 99.04% |
| Profit Margin (Quarterly) | -946.9% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 5.006B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 14.50 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 1.045 |
| Free Cash Flow (Quarterly) | -48.64M |
| Return on Equity (TTM) | -67.03% |
View All NBIX News
NBIX News
-
WireHeadlineTime (ET)
-
Yahoo09/18 08:03
-
PR Newswire09/18 06:25
-
PR Newswire09/15 09:25
-
Yahoo09/12 08:04
-
Yahoo09/11 08:04
-
PR Newswire09/06 14:00
-
MT Newswires09/06 08:52
-
SA Breaking News09/06 08:31
-
PR Newswire09/06 08:01
-
Yahoo09/06 07:37
View All Events
NBIX Events
| Date | Type | Description |
|---|---|---|
| 08/03/2017 14:00 PDT | Misc | Neurocrine Biosciences Inc Second Quarter Earnings Conference Call in 2017 |
| 08/03/2017 | Earnings | Neurocrine Biosciences Inc Second Quarter Earnings in 2017 Release |
| 05/22/2017 | Misc | Neurocrine Biosciences Inc Annual General Meeting in 2016 |
| 05/09/2017 17:00 EDT | Misc | Neurocrine Biosciences Inc First Quarter Earnings Conference Call in 2017 |
| 05/09/2017 | Earnings | Neurocrine Biosciences Inc First Quarter Earnings in 2017 Release |
| 02/14/2017 17:00 EST | Misc | Neurocrine Biosciences Inc Fourth Quarter Earnings Conference Call in 2016 |
| 02/14/2017 | Earnings | Neurocrine Biosciences Inc Fourth Quarter Earnings in 2016 Release |
| 11/02/2016 17:00 EDT | Misc | Neurocrine Biosciences Inc Third Quarter Earnings Conference Call in 2016 |
| 11/02/2016 | Earnings | Neurocrine Biosciences Inc Third Quarter Earnings in 2016 Release |
NBIX Fundamentals
Income Statement View Statement
NBIX Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
NBIX One Page Reports
- One Page Report Download
NBIX Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 56.74 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.neurocrine.com
- Investor Relations URL: http://phoenix.corporate-ir.net/phoenix.zhtml?c=68817&p=irol-news&nyo=0
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Next Earnings Release: N/A
- Last Earnings Release: Aug. 03, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Dec. 29, 1995
- Description: Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.
NBIX Comparables
EditNBIX Excel Add-In Codes
- Name: =YCI("NBIX","name")
- Description: =YCI("NBIX","description")
- Sector: =YCI("NBIX","sector")
- Industry: =YCI("NBIX","industry")
- Est. Current Fiscal Year End: =YCI("NBIX","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other NBIX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- NBIX Tweets Stocktwits
Advertisement
